| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| John Schwartz | M | - |
AcuityBio Corp.
 AcuityBio Corp. Pharmaceuticals: MajorHealth Technology AcuityBio Corp. engages in the commercialization of novel polymer drug-delivery technologies to treat various types of early stage, soft tissue cancers. It offers ABC103 solution. The company was founded by Mark Grinstaff, Alain Hanover, Jesse Wolinsky, and John Schwartz in 2009 and is headquartered in Newtonvillen, MA. | 15 years |
| Mark W. Grinstaff | M | - |
AcuityBio Corp.
AcuityBio Corp. Pharmaceuticals: MajorHealth Technology AcuityBio Corp. engages in the commercialization of novel polymer drug-delivery technologies to treat various types of early stage, soft tissue cancers. It offers ABC103 solution. The company was founded by Mark Grinstaff, Alain Hanover, Jesse Wolinsky, and John Schwartz in 2009 and is headquartered in Newtonvillen, MA. | 15 years |
| Eyal S. Ron | M | 69 |
AcuityBio Corp.
AcuityBio Corp. Pharmaceuticals: MajorHealth Technology AcuityBio Corp. engages in the commercialization of novel polymer drug-delivery technologies to treat various types of early stage, soft tissue cancers. It offers ABC103 solution. The company was founded by Mark Grinstaff, Alain Hanover, Jesse Wolinsky, and John Schwartz in 2009 and is headquartered in Newtonvillen, MA. | 15 years |
| Peter Lui | M | - |
AcuityBio Corp.
AcuityBio Corp. Pharmaceuticals: MajorHealth Technology AcuityBio Corp. engages in the commercialization of novel polymer drug-delivery technologies to treat various types of early stage, soft tissue cancers. It offers ABC103 solution. The company was founded by Mark Grinstaff, Alain Hanover, Jesse Wolinsky, and John Schwartz in 2009 and is headquartered in Newtonvillen, MA. | - |
| Bill Keogh | M | - |
AcuityBio Corp.
AcuityBio Corp. Pharmaceuticals: MajorHealth Technology AcuityBio Corp. engages in the commercialization of novel polymer drug-delivery technologies to treat various types of early stage, soft tissue cancers. It offers ABC103 solution. The company was founded by Mark Grinstaff, Alain Hanover, Jesse Wolinsky, and John Schwartz in 2009 and is headquartered in Newtonvillen, MA. | 3 years |
Multi-company connection
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Alain J. Hanover | M | 75 |
AcuityBio Corp.
AcuityBio Corp. Pharmaceuticals: MajorHealth Technology AcuityBio Corp. engages in the commercialization of novel polymer drug-delivery technologies to treat various types of early stage, soft tissue cancers. It offers ABC103 solution. The company was founded by Mark Grinstaff, Alain Hanover, Jesse Wolinsky, and John Schwartz in 2009 and is headquartered in Newtonvillen, MA. | - |
| Jesse Wolinsky | M | - |
AcuityBio Corp.
AcuityBio Corp. Pharmaceuticals: MajorHealth Technology AcuityBio Corp. engages in the commercialization of novel polymer drug-delivery technologies to treat various types of early stage, soft tissue cancers. It offers ABC103 solution. The company was founded by Mark Grinstaff, Alain Hanover, Jesse Wolinsky, and John Schwartz in 2009 and is headquartered in Newtonvillen, MA. | - |
| Country | Connections | % of total |
|---|---|---|
| United States | 7 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
